SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 193 filers reported holding SAREPTA THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is 0.79 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $0 | – | 20 | +100.0% | 0.00% | – |
| Q4 2017 | $0 | -100.0% | 10 | -91.7% | 0.00% | -100.0% |
| Q3 2017 | $3,000 | -62.5% | 120 | -60.0% | 0.00% | -84.0% |
| Q1 2017 | $8,000 | -100.0% | 300 | -63.4% | 0.02% | -51.9% |
| Q3 2016 | $60,678,000 | +193.7% | 820 | +530.8% | 0.05% | +173.7% |
| Q2 2016 | $20,662,000 | +51555.0% | 130 | +712.5% | 0.02% | – |
| Q1 2016 | $40,000 | -99.8% | 16 | -96.8% | 0.00% | -100.0% |
| Q4 2015 | $19,290,000 | – | 500 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 2,878,979 | $69,182,000 | 7.27% |
| Eventide Asset Management | 259,100 | $6,226,000 | 0.97% |
| GLADE BROOK CAPITAL PARTNERS LLC | 251,000 | $6,032,000 | 0.93% |
| IMS Capital Management | 32,215 | $774,000 | 0.91% |
| Perceptive Advisors | 350,000 | $8,413,000 | 0.88% |
| Benchmark Capital Advisors | 34,900 | $839,000 | 0.58% |
| BECK CAPITAL MANAGEMENT, LLC | 24,744 | $636,000 | 0.49% |
| SABBY MANAGEMENT, LLC | 352,100 | $8,461,000 | 0.47% |
| Hatteras Alternative Mutual Funds, LLC | 39,404 | $947,000 | 0.46% |
| Potomac Capital Management, Inc. | 22,100 | $531,000 | 0.45% |